<DOC>
	<DOCNO>NCT01253603</DOCNO>
	<brief_summary>This study ass safety , efficacy pharmacokinetics QAW039 steroid-free patient mild moderate persistent asthma .</brief_summary>
	<brief_title>Efficacy , Safety , Pharmacokinetics QAW039</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patients medical history mild moderate persistent allergic asthma . Patients must weigh least 45 kg participate study , must abody mass index ( BMI ) &gt; 17 kg/m2 . Female patient must surgically sterilize , postmenopausal use doublebarrier method contraception Women childbearing potential . Smokers define history smoke previous 6 month smoke history 10 pack year , pack year define smoke equivalent 20 cigarette pack every day period 1 year Patients severe persistent asthma Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Asthma</keyword>
</DOC>